Annual Operating Profit
-$82.38 M
-$3.73 M-4.74%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual operating income is -$82.38 million, with the most recent change of -$3.73 million (-4.74%) on December 31, 2023.
- During the last 3 years, OCUL annual operating profit has fallen by -$19.54 million (-31.08%).
- OCUL annual operating profit is now -538.47% below its all-time high of -$12.90 million, reached on December 31, 2013.
Performance
OCUL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$46.00 M
-$2.41 M-5.52%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly operating income is -$46.00 million, with the most recent change of -$2.41 million (-5.52%) on September 30, 2024.
- Over the past year, OCUL quarterly operating profit has dropped by -$26.78 million (-139.40%).
- OCUL quarterly operating profit is now -1438.91% below its all-time high of -$2.99 million, reached on June 30, 2013.
Performance
OCUL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$141.25 M
-$26.78 M-23.40%
September 30, 2024
Summary
- As of February 7, 2025, OCUL TTM operating income is -$141.25 million, with the most recent change of -$26.78 million (-23.40%) on September 30, 2024.
- Over the past year, OCUL TTM operating profit has dropped by -$59.56 million (-72.91%).
- OCUL TTM operating profit is now -4516.18% below its all-time high of -$3.06 million, reached on March 31, 2013.
Performance
OCUL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
OCUL Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.7% | -139.4% | -72.9% |
| 3 y3 years | -31.1% | -135.5% | -90.0% |
| 5 y5 years | -39.4% | -98.8% | -64.6% |
OCUL Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.6% | at low | -157.9% | at low | -87.5% | at low |
| 5 y | 5-year | -31.1% | +4.0% | -228.4% | at low | -124.8% | at low |
| alltime | all time | -538.5% | +4.0% | -1438.9% | at low | -4516.2% | at low |
Ocular Therapeutix Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$46.00 M(+5.5%) | -$141.25 M(+23.4%) |
| Jun 2024 | - | -$43.59 M(+37.9%) | -$114.47 M(+25.2%) |
| Mar 2024 | - | -$31.62 M(+57.7%) | -$91.45 M(+11.0%) |
| Dec 2023 | -$82.38 M(+4.7%) | -$20.05 M(+4.4%) | -$82.38 M(+0.8%) |
| Sep 2023 | - | -$19.21 M(-6.6%) | -$81.69 M(-2.8%) |
| Jun 2023 | - | -$20.57 M(-8.8%) | -$84.02 M(+0.8%) |
| Mar 2023 | - | -$22.55 M(+16.5%) | -$83.37 M(+6.0%) |
| Dec 2022 | -$78.65 M(+0.8%) | -$19.36 M(-10.1%) | -$78.65 M(+1.7%) |
| Sep 2022 | - | -$21.54 M(+8.2%) | -$77.34 M(+2.7%) |
| Jun 2022 | - | -$19.92 M(+11.7%) | -$75.33 M(-0.4%) |
| Mar 2022 | - | -$17.83 M(-1.2%) | -$75.64 M(-3.1%) |
| Dec 2021 | -$78.04 M(+24.2%) | -$18.05 M(-7.6%) | -$78.04 M(+5.0%) |
| Sep 2021 | - | -$19.53 M(-3.5%) | -$74.33 M(+8.0%) |
| Jun 2021 | - | -$20.23 M(+0.0%) | -$68.81 M(+3.5%) |
| Mar 2021 | - | -$20.23 M(+41.0%) | -$66.46 M(+5.8%) |
| Dec 2020 | -$62.85 M(-26.8%) | -$14.34 M(+2.4%) | -$62.85 M(-10.1%) |
| Sep 2020 | - | -$14.01 M(-21.7%) | -$69.91 M(-11.6%) |
| Jun 2020 | - | -$17.88 M(+7.6%) | -$79.04 M(-4.5%) |
| Mar 2020 | - | -$16.61 M(-22.4%) | -$82.76 M(-3.5%) |
| Dec 2019 | -$85.80 M(+45.1%) | -$21.40 M(-7.5%) | -$85.80 M(+5.0%) |
| Sep 2019 | - | -$23.14 M(+7.2%) | -$81.68 M(+11.4%) |
| Jun 2019 | - | -$21.60 M(+9.9%) | -$73.36 M(+12.3%) |
| Mar 2019 | - | -$19.66 M(+13.7%) | -$65.32 M(+10.5%) |
| Dec 2018 | -$59.12 M | -$17.28 M(+16.7%) | -$59.12 M(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$14.82 M(+9.2%) | -$54.55 M(-0.7%) |
| Jun 2018 | - | -$13.56 M(+0.8%) | -$54.93 M(-8.0%) |
| Mar 2018 | - | -$13.46 M(+5.8%) | -$59.71 M(-3.6%) |
| Dec 2017 | -$61.92 M(+42.9%) | -$12.72 M(-16.3%) | -$61.92 M(+0.4%) |
| Sep 2017 | - | -$15.20 M(-17.1%) | -$61.68 M(+10.7%) |
| Jun 2017 | - | -$18.34 M(+17.0%) | -$55.72 M(+14.9%) |
| Mar 2017 | - | -$15.67 M(+25.7%) | -$48.49 M(+11.9%) |
| Dec 2016 | -$43.33 M(+13.4%) | -$12.47 M(+35.0%) | -$43.33 M(+5.3%) |
| Sep 2016 | - | -$9.24 M(-16.8%) | -$41.13 M(-4.5%) |
| Jun 2016 | - | -$11.11 M(+5.7%) | -$43.06 M(+3.5%) |
| Mar 2016 | - | -$10.51 M(+2.3%) | -$41.59 M(+8.9%) |
| Dec 2015 | -$38.20 M(+41.0%) | -$10.28 M(-8.0%) | -$38.20 M(+7.7%) |
| Sep 2015 | - | -$11.17 M(+16.0%) | -$35.47 M(+14.2%) |
| Jun 2015 | - | -$9.63 M(+35.5%) | -$31.07 M(+13.5%) |
| Mar 2015 | - | -$7.11 M(-5.8%) | -$27.38 M(+1.1%) |
| Dec 2014 | -$27.09 M(+110.0%) | -$7.55 M(+11.4%) | -$27.09 M(+18.0%) |
| Sep 2014 | - | -$6.78 M(+14.0%) | -$22.97 M(+17.0%) |
| Jun 2014 | - | -$5.95 M(-12.9%) | -$19.63 M(+17.7%) |
| Mar 2014 | - | -$6.83 M(+99.6%) | -$16.67 M(+29.2%) |
| Dec 2013 | -$12.90 M(-5.6%) | -$3.42 M(-0.5%) | -$12.90 M(+36.1%) |
| Sep 2013 | - | -$3.44 M(+14.9%) | -$9.48 M(+56.8%) |
| Jun 2013 | - | -$2.99 M(-2.3%) | -$6.05 M(+97.7%) |
| Mar 2013 | - | -$3.06 M | -$3.06 M |
| Dec 2012 | -$13.67 M | - | - |
FAQ
- What is Ocular Therapeutix annual operating income?
- What is the all time high annual operating profit for Ocular Therapeutix?
- What is Ocular Therapeutix annual operating profit year-on-year change?
- What is Ocular Therapeutix quarterly operating income?
- What is the all time high quarterly operating profit for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly operating profit year-on-year change?
- What is Ocular Therapeutix TTM operating income?
- What is the all time high TTM operating profit for Ocular Therapeutix?
- What is Ocular Therapeutix TTM operating profit year-on-year change?
What is Ocular Therapeutix annual operating income?
The current annual operating profit of OCUL is -$82.38 M
What is the all time high annual operating profit for Ocular Therapeutix?
Ocular Therapeutix all-time high annual operating income is -$12.90 M
What is Ocular Therapeutix annual operating profit year-on-year change?
Over the past year, OCUL annual operating income has changed by -$3.73 M (-4.74%)
What is Ocular Therapeutix quarterly operating income?
The current quarterly operating profit of OCUL is -$46.00 M
What is the all time high quarterly operating profit for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly operating income is -$2.99 M
What is Ocular Therapeutix quarterly operating profit year-on-year change?
Over the past year, OCUL quarterly operating income has changed by -$26.78 M (-139.40%)
What is Ocular Therapeutix TTM operating income?
The current TTM operating profit of OCUL is -$141.25 M
What is the all time high TTM operating profit for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM operating income is -$3.06 M
What is Ocular Therapeutix TTM operating profit year-on-year change?
Over the past year, OCUL TTM operating income has changed by -$59.56 M (-72.91%)